Resmed (ASX:RMD) Chief Financial Officer Brett Sandercock sold 1,000 shares in the company on the New York Stock Exchange for $230,360, according to a filing on Tuesday with the US Securities and Exchange Commission.
Sandercock now holds about 146.9 million shares, the filing said.